HomeInsightsResults

Bharat Parenterals Ltd Quarterly Result

Bharat Parenterals Ltd Quarterly Result

stocks purchased

₹ 1.4 Cr

Volume Transacted

(Nov 22, 2024)

stocks purchased

8.9 K

Stocks Traded

(Nov 22, 2024)

Last Updated on: Nov 23, 2024

Image

Bharat Parenterals Ltd

NSE: BHARATPARENTER

Net Profit

₹ -17.52

Last updated on: Nov 23, 2024

Key Highlights

  • The revenue of Bharat Parenterals Ltd for the Sep '24 is ₹ 75.84 crore as compare to the Jun '24 revenue of ₹ 95.05 crore. This represent the decline of -20.210423%.
  • The ebitda of Bharat Parenterals Ltd for the Sep '24 is ₹ -3.45 crore as compare to the Jun '24 ebitda of ₹ 7.03 crore. This represent the decline of -149%.
  • The net profit of Bharat Parenterals Ltd for the Sep '24 is ₹ -17.52 crore as compare to the Jun '24 net profit of ₹ -8.84 crore. This represent the growth of 98.19004%.

Results Analysis

Market Price of Bharat Parenterals Ltd

1M

1Y

3Y

5Y

Monitoring Bharat Parenterals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
22 Nov 20241602.6
21 Nov 20241526.3
19 Nov 20241490.45
18 Nov 20241499.8
14 Nov 20241500.25
13 Nov 20241469.25
12 Nov 20241446.1
11 Nov 20241454
08 Nov 20241481.3
07 Nov 20241490.5

Historical Revenue of Bharat Parenterals Ltd

No data available

* All values are in crore

Historical EBITDA of Bharat Parenterals Ltd

No data available

* All values are in crore

Historical Net Profit of Bharat Parenterals Ltd

No data available

* All values are in crore

Bharat Parenterals Ltd News Hub

News

Bharat Parenterals to announce Quarterly Result

Bharat Parenterals will hold a meeting of the Board of Directors of the Company on 29 Octo...

Read more

21 Oct 202410:22

News

Bharat Parenterals announces board meeting date

Bharat Parenterals will hold a meeting of the Board of Directors of the Company on 8 Augus...

Read more

01 Aug 202410:54

News

Bharat Parenterals schedules AGM

Bharat Parenterals announced that the Annual General Meeting (AGM) of the company will be ...

Read more

12 Jun 202410:01

News

Bharat Parenterals to hold board meeting

Bharat Parenterals will hold a meeting of the Board of Directors of the Company on 10 June...

Read more

07 Jun 202410:29

News

Bharat Parenterals schedules board meeting

Bharat Parenterals will hold a meeting of the Board of Directors of the Company on 5 June ...

Read more

27 May 202417:42

News

Board of Bharat Parenterals recommends final dividend

Bharat Parenterals announced that the Board of Directors of the Company at its meeting hel...

Read more

23 May 202411:09

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQ's For Bharat Parenterals Ltd Quarterly Result

What is the EPS of Bharat Parenterals Ltd stock?

The Earnings Per Share (EPS) of Bharat Parenterals Ltd is 0.0. An EPS is the amount of net income attributed to each share of a common stock.

How is Bharat Parenterals Ltd EPS calculated?

The EPS of Bharat Parenterals Ltd is calculated by dividing the net income by the number of outstanding shares. The formula is EPS = (Net Income - Dividends on Preferred Stock) / Average Outstanding Shares.

How often does Bharat Parenterals Ltd report its EPS?

Bharat Parenterals Ltd typically reports its EPS quarterly and annually, in conjunction with its financial statements and earnings reports.

What factors can influence Bharat Parenterals Ltd EPS?

Factors that influence the EPS of Bharat Parenterals Ltd include revenue changes, cost fluctuations, operational efficiency, tax rates, and one-time gains or losses.

Can Bharat Parenterals Ltd EPS growth indicate future performance?

Yes, consistent growth in Bharat Parenterals Ltd EPS can suggest strong financial health and effective management, potentially indicating positive future performance.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*